Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Bayer Stock News

BAYZFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$26.39

0.110.40%

At close: -

$30.72

4.3216.39%

After Hours: May 31, 8:52 AM EDT

Bayer (BAYZF) Forecast

News

Earnings Bayer (BAYZF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Bayer Stock News | OTC:BAYZF | Benzinga

Get the latest news on Bayer stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Bayer performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, November 12, 2024

Bayer Confirms Its 2024 Guidance, Sales Of €4...
Benzinga Newsdesk - Nov 12, 2024, 3:09AM

Thursday, July 25, 2024

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Vandana Singh - Jul 25, 2024, 2:35PM

Wednesday, June 05, 2024

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Vandana Singh - Jun 5, 2024, 10:06AM

Friday, May 24, 2024

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Vandana Singh - May 24, 2024, 12:00PM

Friday, May 17, 2024

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Vandana Singh - May 17, 2024, 11:02AM

Thursday, May 02, 2024

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Vandana Singh - May 2, 2024, 1:38PM

Tuesday, March 19, 2024

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Vandana Singh - Mar 19, 2024, 9:31AM

Thursday, March 14, 2024

German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Vandana Singh - Mar 14, 2024, 3:59PM

Wednesday, March 06, 2024

Boundless Bio Files For IPO; Applies To List ...
Benzinga Newsdesk - Mar 6, 2024, 4:58PM

Tuesday, March 05, 2024

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Vandana Singh - Mar 5, 2024, 3:25PM

Monday, March 04, 2024

What's Going On With BridgeBio Pharma Stock On Monday?
Vandana Singh - Mar 4, 2024, 12:31PM

Tuesday, January 30, 2024

Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Vandana Singh - Jan 30, 2024, 7:49AM

Monday, January 29, 2024

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Vandana Singh - Jan 29, 2024, 9:41AM

Thursday, January 11, 2024

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Vandana Singh - Jan 11, 2024, 11:40AM

Monday, January 08, 2024

Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Vandana Singh - Jan 8, 2024, 1:11PM

Thursday, January 04, 2024

Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Vandana Singh - Jan 4, 2024, 10:57AM

Tuesday, December 26, 2023

Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Vandana Singh - Dec 26, 2023, 6:58AM

Tuesday, December 19, 2023

ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Surbhi Jain - Dec 19, 2023, 8:59AM

Wednesday, December 06, 2023

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Vandana Singh - Dec 6, 2023, 12:49PM

Monday, December 04, 2023

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Vandana Singh - Dec 4, 2023, 1:39PM

Friday, November 24, 2023

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Vandana Singh - Nov 24, 2023, 12:48PM

Monday, November 20, 2023

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Vandana Singh - Nov 20, 2023, 2:58PM
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Vandana Singh - Nov 20, 2023, 1:34PM

Friday, November 17, 2023

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Vandana Singh - Nov 17, 2023, 6:05AM

Wednesday, November 08, 2023

Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
Vandana Singh - Nov 8, 2023, 11:15AM

Wednesday, November 01, 2023

Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
Vandana Singh - Nov 1, 2023, 1:31PM

Friday, September 22, 2023

From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Vandana Singh - Sep 22, 2023, 7:49AM

Monday, August 28, 2023

Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
Vandana Singh - Aug 28, 2023, 10:37AM
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Vandana Singh - Aug 28, 2023, 10:02AM

Monday, August 21, 2023

FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
Vandana Singh - Aug 21, 2023, 8:37AM

Tuesday, August 08, 2023

Bayer Lowered Its FY23 Outlook, Now Sees Sale...
Benzinga Newsdesk - Aug 8, 2023, 3:00AM
Bayer Q2 EPS $0.33 Beats $0.31 Estimate, Sale...
Benzinga Newsdesk - Aug 8, 2023, 2:52AM

Thursday, June 29, 2023

AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
Vandana Singh - Jun 29, 2023, 1:39PM

Wednesday, June 28, 2023

Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
Vandana Singh - Jun 28, 2023, 9:20AM

Tuesday, April 04, 2023

US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Vandana Singh - Apr 4, 2023, 7:47AM

Friday, March 10, 2023

Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
Vandana Singh - Mar 10, 2023, 8:34AM

Wednesday, January 18, 2023

Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Vandana Singh - Jan 18, 2023, 8:45AM

Wednesday, January 11, 2023

FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top Stories
Vandana Singh - Jan 11, 2023, 9:23AM
Activist Investor Builds Stake In Bayer, Pushes Breakup
Vandana Singh - Jan 11, 2023, 8:14AM

Friday, November 04, 2022

Ionis Regains Rights To Thrombosis Candidate From Bayer
Vandana Singh - Nov 4, 2022, 10:33AM

Wednesday, October 05, 2022

Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
Vandana Singh - Oct 5, 2022, 7:37AM

Wednesday, September 14, 2022

After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
Vandana Singh - Sep 14, 2022, 7:58AM

Thursday, September 08, 2022

Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Vandana Singh - Sep 8, 2022, 10:11AM

Monday, August 29, 2022

Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
Vandana Singh - Aug 29, 2022, 1:47PM

Monday, August 08, 2022

FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
Vandana Singh - Aug 8, 2022, 6:22AM

Friday, June 10, 2022

Morning Brief: Top Financial Stories Dominating on Friday, June 10
Akanksha Bakshi - Jun 10, 2022, 8:03AM
US Top Court To Decide On Bayer's Roundup Weedkiller Appeal
Anusuya Lahiri - Jun 10, 2022, 7:32AM

Friday, May 20, 2022

Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
Vandana Singh - May 20, 2022, 6:49AM

Thursday, April 21, 2022

FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
Vandana Singh - Apr 21, 2022, 3:08PM

Tuesday, March 15, 2022

Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
Vandana Singh - Mar 15, 2022, 3:41PM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved